Alkem Laboratories Limited
ALKEM
Rangering i aksjer
#2826
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aksjekurs
$55.05
Markedsverdi
$6.58B
Endring (1 dag)
-0.31%
Endring (1 år)
-12.65%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
EPS for Alkem Laboratories Limited (ALKEM)
EPS per June 2026 TTM: $1.99
Ifølge de siste økonomiske rapportene og aksjekursen til Alkem Laboratories Limited er selskapets nåværende EPS (TTM) $1.99. Ved slutten av 2024 hadde selskapet en EPS på $1.80, en økning sammenlignet med EPS-en i 2023 som var $1.00.
EPS-historikk for Alkem Laboratories Limited fra 2010 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $1.99 | -6.17% |
| 2025 | $2.12 | 17.57% |
| 2024 | $1.80 | 79.83% |
| 2023 | $1.00 | -44.76% |
| 2022 | $1.81 | 0.12% |
| 2021 | $1.81 | 44.74% |
| 2020 | $1.25 | 36.59% |
| 2019 | $0.92 | 13.02% |
| 2018 | $0.81 | -29.55% |
| 2017 | $1.15 | 22.89% |
| 2016 | $0.94 | 78.39% |
| 2015 | $0.52 | -14.30% |
| 2014 | $0.61 | -19.80% |
| 2013 | $0.76 | 8.82% |
| 2012 | $0.70 | 15.60% |
| 2011 | $0.61 | 38.68% |
| 2010 | $0.44 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -72.03% |
IN
|
